Observational Study of Rapid Sequence Intubation (RSI) Drug Delivery Using Intraosseous (IO) and Intravenous (IV) Access.

Study Overview
=================
Brief Summary
-----------------
This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.

Detailed Description
-----------------
This observational study will evaluate the intubating conditions of patients receiving rapid sequence intubation when receiving paralytic drug delivery via intravenous or intraosseous vascular access from the perspective of the medical professional performing rapid sequence intubation. The investigators believe that medical professionals will find equal intubating conditions for intravenous and intraosseous drug delivery.

Official Title
-----------------
An Observational Study of Intubating Conditions Comparing Intraosseous Vascular Access With Peripheral Intravenous Access for Drug Delivery in Rapid Sequence Intubation

Conditions
-----------------
Airway Control

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Requires rapid sequence intubation Succinylcholine is chosen paralytic agent IV or IO access has been established for rapid sequence intubation For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO RSI case. Exclusion Criteria: Vascular access other than IV or IO has been established
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Intravenous (IV) drug delivery<br>patients on whom intravenous vascular access has been established for the purpose of rapid sequence intubation drug delivery. | |
| Intraosseous (IO) drug delivery<br>Patients on whom intraosseous vascular access has been established for rapid sequence intubation drug delivery. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Time from first drug delivery to operator-perceived sufficient relaxation to perform endotracheal tube placement |  | during rapid sequence intubation procedure, average expected time frame 30 minutes | 
| Intubation difficulty using the intubation difficulty scale |  | during rapid sequence intubation procedure, average expected time frame 30 minutes | 
| Operator satisfaction with intubating conditions using visual analog scale |  | during rapid sequence intubation procedure, average expected time frame 30 minutes | 
| Failure rate of endotracheal intubation and requirement for alternative airway management methods |  | during rapid sequence intubation procedure, average time frame 30 minutes | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of short-term catheter related complications for each technique |  | during emergency department stay, average time frame 24 hours | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Airway management